Topic: TACE Global Summit III : The Combination Therapy

Moderator:
Dr. Robert Lewandowski, MD, Prof.
Director of Interventional Oncology Northwestern University, USA

Agenda and Speakers:

Immune landscape after liver directed therapy in hepatocellular carcinoma (HCC) and potential for combination therapy
Dr. Rony Arvitscher, MD. Prof., Co-chair of pre-clinical research Program
MD Anderson Cancer Center, USA

Current clinical practice and studies of TACE combined with anti-angiogenesis and immunotherapy
Dr. Toshihiro Tanaka, MD, PhD., Prof., Dept. of Radiology Chair
Nara Medical University Hospital, Japan

Combination Therapy for Hepatocellular Carcinoma - Experience in China
Dr. Long Jin, MD, PhD., Prof., Director of IR
Beijing Friendship Hospital, Capital Medical University, China

Panelist discussion and Q&A

Discussion Panelists:
Dr. Jian Wang
Beijing University First Hospital

Dr. Jie Pan
Beijing Union Medical College Hospital

Sponsored by Boston Scientific